Sign in
Stories
Burning Rock Biotech and Harvard Bioscience to Announce Q2 2023 Financial Results
Share
Biopharmaceutical Companies' Q2 Results
Conference Calls for Balchem and Ashland
Dyadic's Animal-Free Serum Albumin Progr...
AB Ignitis grup to Present 6M 2023 Resul...
AB Ignitis grup to Present 6M 2023 Resul...
Amarin Q1 2024 Financial Update
Overview
API
Burning Rock Biotech and Harvard Bioscience plan to release their financial results for the second quarter of 2023. Burning Rock Biotech expects positive revenue growth driven by in-hospital and pharma service business segments. Harvard Bioscience is a leading developer in the life science industry.
Ask a question
How does Harvard Bioscience's position in the life science industry impact its financial results?
What are the potential implications of Burning Rock Biotech's focus on precision oncology?
What factors contributed to Burning Rock Biotech's positive revenue growth?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
May 2023
Jun 2023
Jul 2023
Coverage